Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KYMR | MRNA | BMY | AMGN | BNTX |
| Company | Kymera Therapeutics Inc | Moderna Inc | Bristol-Myers Squibb Company | Amgen Inc | Biontech Se ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 34.87 | 102.79 | 49.00 | 269.84 | 86.88 |
| High | 35.37 | 105.43 | 49.56 | 273.14 | 88.72 |
| Low | 33.85 | 99.30 | 48.87 | 269.84 | 86.50 |
| Last | 34.35 | 104.46 | 49.14 | 271.91 | 88.01 |
| Change | +0.38 | +3.05 | +0.21 | +2.98 | +1.20 |
| % Change | +1.12% | +3.01% | +0.43% | +1.11% | +1.38% |
| Volume | 417,200 | 3,176,300 | 7,929,500 | 2,165,700 | 528,400 |
| 20-Day Average Volume | 504,835 | 3,320,895 | 11,113,590 | 2,239,560 | 588,815 |
| Previous Close | 33.97 | 101.41 | 48.93 | 268.93 | 86.81 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 36.69 | 105.27 | 50.71 | 272.35 | 89.45 |
| 20-Day Raw Stochastic | 14.46% | 39.49% | 22.23% | 40.27% | 30.92% |
| 20-Day Relative Strength | 42.51% | 51.78% | 42.35% | 47.06% | 43.89% |
| Weighted Alpha | +9.59 | -13.38 | -25.43 | +10.54 | -23.94 |
| Today's Opinion | 40% Buy | 72% Buy | 88% Sell | 40% Sell | 100% Sell |
| Previous Opinion | 40% Buy | 72% Buy | 72% Sell | 56% Sell | 100% Sell |
| Last Month's Opinion | 80% Buy | 64% Buy | 24% Sell | 8% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.12% since 04/15/24 | +0.58% since 04/15/24 | +1.30% since 04/15/24 | +2.41% since 04/15/24 | +0.14% since 04/15/24 |
| Low | 33.17 on 04/17/24 | 99.30 on 04/22/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 85.40 on 04/17/24 |
| High | 35.57 on 04/18/24 | 106.42 on 04/16/24 | 49.56 on 04/22/24 | 273.14 on 04/22/24 | 88.72 on 04/22/24 |
| 1-Month | |||||
| %Chg | -15.64% since 03/22/24 | -0.92% since 03/22/24 | -5.37% since 03/22/24 | -1.54% since 03/22/24 | -4.16% since 03/22/24 |
| Low | 33.17 on 04/17/24 | 97.00 on 04/03/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 85.40 on 04/17/24 |
| High | 41.33 on 03/25/24 | 115.89 on 04/09/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 93.84 on 03/28/24 |
| 3-Month | |||||
| %Chg | +17.28% since 01/22/24 | +4.77% since 01/22/24 | -0.87% since 01/22/24 | -12.33% since 01/22/24 | -11.82% since 01/22/24 |
| Low | 29.37 on 01/23/24 | 84.06 on 02/13/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 85.21 on 03/20/24 |
| High | 45.31 on 02/27/24 | 115.89 on 04/09/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 101.13 on 01/24/24 |
| 6-Month | |||||
| %Chg | +182.72% since 10/20/23 | +29.93% since 10/20/23 | -12.96% since 10/20/23 | -2.47% since 10/20/23 | -3.19% since 10/20/23 |
| Low | 9.60 on 11/02/23 | 62.55 on 11/02/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 85.21 on 03/20/24 |
| High | 45.31 on 02/27/24 | 115.97 on 01/08/24 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 114.69 on 01/02/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,075,974 | 38,827,864 | 99,169,320 | 144,247,584 | 20,636,992 |
| Shares Outstanding, K | 61,112 | 382,880 | 2,026,759 | 536,376 | 237,726 |
| Annual Sales | 78,590,000 | 6,848,000,000 | 45,006,000,000 | 28,190,000,000 | 4,133,300,000 |
| Annual Net Income | -146,960,000 | -4,714,000,000 | 8,025,000,000 | 6,717,000,000 | 1,006,860,000 |
| Last Quarter Sales | 47,890,000 | 2,811,000,000 | 11,477,000,000 | 8,196,000,000 | 1,605,270,000 |
| Last Quarter Net Income | -14,370,000 | 217,000,000 | 1,762,000,000 | 767,000,000 | 500,620,000 |
| 60-Month Beta | 2.27 | 1.62 | 0.39 | 0.58 | 0.23 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.25 on 02/22/24 | 0.55 on 02/22/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 2.05 on 03/20/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 04/25/24 | 05/02/24 | 05/06/24 |
| Most Recent Dividend | N/A | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 3.084 on 06/02/22 |
| Next Ex-Dividends Date | N/A | N/A | 04/04/24 | 05/16/24 | 06/02/22 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 6.44 | 14.09 | 20.92 |